BPI-5143

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameBPI-5143

Drug Alias Namecytochrome P450 CYP17A inhibitors (Beta Pharma)BPI-5143

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitors

TargetsSteroid 17-alpha-hydroxylase

Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBeta Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBeta Pharma Inc

Active IndicationsN/A

Inactive IndicationsHormone-Resistant Prostate Neoplasms

ATC CodeN/A